Ra Pharmaceuticals, Inc.
(NASDAQ : RARX)

( )
RARX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson -1.46%131.070.7%$2087.30m
PFEPfizer Inc. 0.00%32.670.9%$1426.13m
MRKMerck & Co., Inc. 0.05%76.990.7%$1342.58m
ABBVAbbVie, Inc. 1.34%76.252.3%$1267.83m
BMYBristol-Myers Squibb Co. 2.50%55.751.0%$1116.68m
LLYEli Lilly & Co. 0.34%138.911.1%$930.14m
FTSVForty Seven, Inc. 0.05%95.420.0%$328.86m
NVSNovartis AG 0.65%82.430.2%$312.37m
AZNAstraZeneca Plc 0.36%44.691.2%$293.79m
GSKGlaxoSmithKline Plc 0.82%37.910.2%$277.70m
NVONovo Nordisk A/S 0.00%60.180.1%$182.23m
SNYSanofi -2.17%43.720.2%$161.58m
BHCBausch Health Cos., Inc. 1.77%15.520.0%$106.65m
RARXRa Pharmaceuticals, Inc. 1.42%48.010.8%$78.59m
RGENRepligen Corp. 0.75%96.547.1%$73.78m

Company Profile

Ra Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of peptide-based drugs. It uses Extreme Diversity platform that allows to produce synthetic macrocyclic peptides. The company was founded by James W. Broderick and Douglas A. Treco on June 27, 2008 and is headquartered in Cambridge, MA.